SIXPEX Aromapex 25 (USA DOMESTIC)

Aromapex 25 is a medication used in the treatment of breast cancer. It belongs to a class of drugs called aromatase inhibitors. Aromatase inhibitors work by reducing the amount of estrogen produced in the body, which is beneficial in hormone receptor-positive breast cancer.

Here are some key points about Aromapex 25:

Medical Uses: Aromapex 25 is primarily used to treat postmenopausal women with hormone receptor-positive early or advanced breast cancer. It is often prescribed after other treatments, such as surgery or tamoxifen, have been tried. Aromapex 25 can help prevent the recurrence of breast cancer and improve overall survival rates.

Mechanism of Action: Aromapex 25 works by inhibiting the enzyme aromatase, which is responsible for the conversion of androgens (male hormones) into estrogens (female hormones). By blocking this enzyme, it reduces the levels of estrogen in the body, which can slow down the growth of hormone receptor-positive breast cancer cells.

Dosage and Administration: Aromapex 25 is available in tablet form and is typically taken once a day after a meal. The recommended dose is 25 milligrams (mg) per day. It is important to follow the prescribed dosage and duration of treatment as directed by your healthcare provider.

Side Effects: Like any medication, Aromapex 25 can cause side effects. Common side effects may include hot flashes, sweating, fatigue, joint pain, headache, nausea, and insomnia. Some women may experience more severe side effects such as bone loss, osteoporosis, or an increased risk of fractures.

Precautions and Contraindications: Aromapex 25 is generally not recommended for use in premenopausal women or men. It is also contraindicated in individuals who have a known allergy to Aromapex 25 or any of its components.

Hormone Replacement Therapy: Aromapex 25 should not be used in combination with hormone replacement therapy (HRT) or estrogen-containing medications. The use of Aromapex 25 may interfere with the effectiveness of these treatments.